Assembly Biosciences Inc (ASMB) — Long-term Investment Intensity

Latest as of June 2022: 8.3%

Assembly Biosciences Inc (ASMB) has a Long-term Investment Intensity of 8.3% as of June 2022. Long-term investments of $11.91 Million represent 8.3% of total assets of $143.45 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ASMB cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

8.3%
LT Investments / Total Assets

Long-term Investments

$11.91 Million
USD

Total Assets

$143.45 Million
USD

Country

USA
NASDAQ

Assembly Biosciences Inc Long-term Investment Intensity (2015–2021)

This chart shows how Assembly Biosciences Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2021. As of June 2022, the intensity stands at 8.3%, reflecting long-term investments of $11.91 Million against total assets of $143.45 Million USD. For the complete balance sheet picture, see Assembly Biosciences Inc total assets.

Annual Long-term Investment Intensity for Assembly Biosciences Inc (2015–2021)

The table below presents the year-by-year Long-term Investment Intensity for Assembly Biosciences Inc from 2015 to 2021, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Assembly Biosciences Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2021 14.6% $27.97 Million $191.06 Million ▲ +12.7 pp
2017 2.0% $3.35 Million $169.30 Million ▼ -0.5 pp
2016 2.5% $2.44 Million $98.12 Million ▼ -15.0 pp
2015 17.5% $23.39 Million $133.74 Million
pp = percentage points